25.03.2025 – 08:01ARTTIC Innovation GmbHSGLT2 HYPE: New EU-funded Project Aims to Transform Hypertension TreatmentSGLT2 HYPE websitemore
24.03.2025 – 10:36Ottobock SE & Co. KGaAOttobock invests in innovative technologies from MIT Start-upsAbout Ottobockmore
07.03.2025 – 07:31STADA Arzneimittel AG3Press Release STADA’s growth journey continues in 2024 - Significant increase in sales and profits - Growing ahead of the marketOne documentmore
14.01.2025 – 12:00LTS Lohmann Therapie-Systeme AGLTS wins funding from BARDA’s Patch Forward Prize Competition for two partnershipsmore
14.01.2025 – 11:15Helmholtz MunichSCP-Nano: A New Technology to Visualize Nanocarriers in Cells and Tissuesmore
09.01.2025 – 10:27Grünenthal GroupGrünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officermore
19.12.2024 – 11:43RHEACELL GmbH und Co. KGRHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcersmore
16.12.2024 – 10:27Gerresheimer AGGerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU*more
29.11.2024 – 11:30Strides Pharma International AGStrides Pharma Consolidates European Business-to-Business Operations in Switzerlandmore
25.11.2024 – 13:52Helmholtz MunichInceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapiesmore
24.10.2024 – 08:09Ottobock SE & Co. KGaAOttobock invests in NeuroTech company ONWARD® MedicalOttobock Newsroommore
16.10.2024 – 14:00ARTTIC Innovation GmbHEvent Announcement: VIROFIGHT Hybrid SymposiumRegister HereOne documentmore
24.09.2024 – 12:25RHEACELL GmbH und Co. KGRHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVUmore
09.09.2024 – 09:06Sysmex Europe SE2Fundació Puigvert validates a new tool capable of selecting the most suitable antibiotic for uncomplicated urinary tract infections within 45 minutes.Visit our website!One documentmore
04.09.2024 – 15:13Fördergesellschaft IZB mbH2Record financing rounds at the Munich biotech hubFind out more about the 40+ biotech start-ups at the IZBOne documentmore
03.09.2024 – 11:10Bosch Healthcare Solutions GmbHNear-patient PCR rapid test for whooping cough for Vivalytic by Bosch now available / World's first fully automated PCR test for detection of B. pertussis, B. parapertussis, B. holmesiimore
29.08.2024 – 14:03ARTTIC Innovation GmbHcanSERV relaunches Open Call for Service ProvisionOpen CallOne documentmore
28.08.2024 – 07:34STADA Arzneimittel AGPress release: STADA continues strong growth journey in the first half of 2024One documentmore
18.07.2024 – 11:05Bosch Healthcare Solutions GmbHPCR rapid test for 3 important gastroenteritis pathogens for Vivalytic by Bosch now available / World’s first fully automated PCR test for detection of C. difficile, norovirus, and rotavirus at the sampling pointmore
17.07.2024 – 09:42Grünenthal Group2Grünenthal announces significant investments in its Latin America production sites, further securing reliable medicine supply for patientsmore
13.06.2024 – 10:05Sysmex Europe SE4Sysmex’s PA-100 AST System Wins One of the UK’s Biggest Science PrizesVisit our website!One documentmore
28.05.2024 – 14:05ARTTIC Innovation GmbHcanSERV invites applications for "Revolutionising Cancer Patient Care"canSERV Challenge CallOne documentmore
28.05.2024 – 14:00ARTTIC Innovation GmbH3canSERV invites applications for "Revolutionising Cancer Patient Care"canSERV CallOne documentmore
16.05.2024 – 13:40Helios Gesundheit3Seminar on Echocardiography: TEE Masterclass – live stream from the operating theatres of Leipzig Heart CenterMore informationmore
29.04.2024 – 13:00Gerresheimer AG2Gerresheimer partners with RxCap to offer connected adherence solutionsmore
16.04.2024 – 11:14Ottobock SE & Co. KGaA3Milestones in mobility - Ottobock at OTWorld 2024More information about Ottobockmore